Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates

By Al-Azzawi Farook  

Gynecological Endocrinology, Vol. 24, Iss. 11, 2008-01 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite

Optimizing Administration of Bisphosphonates in Women with Postmenopausal Osteoporosis

By Rackoff Paula J.   Sebba Anthony  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 245-251

Adis International

Access to resources Recommend Favorite

Combining Bisphosphonates with Hormone Therapy for Postmenopausal Osteoporosis

By Fadanelli Margaret E.  

Treatments in Endocrinology, Vol. 3, Iss. 6, 2004-01 ,pp. : 361-369

Adis International

Access to resources Recommend Favorite

Strontium ranelate: a new alternative treatment for postmenopausal osteoporosis

By Karsdal Morten A   Christiansen Claus  

Future Rheumatology, Vol. 1, Iss. 6, 2006-12 ,pp. : 683-692

Future Medicine

Access to resources Recommend Favorite

Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review

By Gallacher S.  

Calcified Tissue International, Vol. 87, Iss. 6, 2010-12 ,pp. : 469-484

Springer Publishing Company

Access to resources Recommend Favorite